At USD 23.16 billion in 2024 and advancing at a 5.5% CAGR through 2034, the U.S. analytical instrumentation market is undergoing a profound segmentation-driven transformation, where growth is no longer uniform but intensely shaped by end-user verticals, application specificity, and product architecture. Life sciences remains the dominant segment, fueled by biologics development, cell and gene...